Moss Genomics

Moss Genomics Current Liabilities

The Current Liabilities of Moss Genomics (MOSS.CN) as of Nov 3, 2026 is 253,955.00 CAD. In the previous year, Current Liabilities was 93,836.00 CAD — a change of 170.64% (higher).

Current Liabilities

253,955.00CAD

YoY

170.64%

Last updated:

Current Liabilities of Moss Genomics is 2025 253,955.00 CAD. Current Liabilities of Moss Genomics was 2024 93,836.00 CAD. It decreases by 170.64% higher compared to the previous year.

The Moss Genomics Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2020
12,200.00 CAD
Jan 1, 2021
120,500.00 CAD
Jan 1, 2022
21,900.00 CAD
Jan 1, 2023
0.00 CAD
Jan 1, 2024
93,836.00 CAD
Jan 1, 2025
253,955.00 CAD
The Moss Genomics Current Liabilities history
YEARCurrent LiabilitiesYoY
253,955.00CAD+170.64%
93,836.00CAD—
0.00CAD-100.00%
21,900.00CAD-81.83%
120,500.00CAD+887.70%
12,200.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Moss Genomics Stock analysis

What does Moss Genomics do? Moss Genomics, Inc. generates revenue through personalized health, anti-aging, and wellness offerings guided by genomic, microbiome, and epigenome data. The company sells products like Gut Health Complete, Gut + Mental Health Complete, and Personalized Probiotic Products. Its services include home collection kits for saliva and fecal samples, genomic and gut microbiome sequencing, and health reports with actionable wellness recommendations. The firm targets consumers seeking tailored health solutions, leveraging AI to analyze DNA and gut microbiome data. Moss Genomics Holdings Inc., its wholly owned subsidiary, supports these offerings. The company operates in San Diego, California, and offers a Multi-Omics Database to improve pharma and biotech drug development. This database integrates genomic, microbiome, and epigenome data from its consumer base, providing value to pharmaceutical and biotech partners. Moss Genomics, Inc. focuses on delivering personalized health insights through its consumer genetic testing segment, which complements its broader health and wellness product line. Moss Genomics, Inc. provides home collection kits for sample gathering, followed by sequencing and analysis to produce health reports. These reports guide users toward personalized wellness strategies, driving customer engagement and repeat purchases. The company’s business model combines direct-to-consumer health products with data-driven insights for the pharmaceutical industry, creating dual revenue streams from both individual consumers and corporate clients. Moss Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moss Genomics stock

Current Liabilities of Moss Genomics is 253,955.00 CAD in 2025.

Current Liabilities of Moss Genomics changed from 93,836.00 CAD to 253,955.00 CAD, representing a 170.64% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Moss Genomics since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Moss Genomics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Moss Genomics

All Key Metrics — Moss Genomics